They found that people who had been prescribed these drugs more frequently, or who took multiple types, had a higher risk of ...
A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...
Hosted on MSN14d
Supernus wins FDA approval for Parkinson’s pump on fourth trySupernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been marked by ...
Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that ...
And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...
A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease ... of antihypertensive drugs: angiotensin-converting ...
The 194 people with Parkinson’s disease involved ... Researchers identify 21 existing drugs that could treat coronavirus Check out the Valentine Week List 2025, along with the Valentine ...
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds By India Edwards HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers. The world's largest and longest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback